Navigation Links
Research Highlights Potential Benefits of Telemedicine in Treating Eye Disease
Date:11/12/2007

NEW ORLEANS, Nov. 12 /PRNewswire/ -- Two studies being presented at the American Academy of Ophthalmology's 2007 Annual Meeting suggest that telemedicine may have a significant role to play in the diagnosis of eye diseases, increased patient compliance and patient access to quality care.

In the first study, researchers examined the impact that telemedicine had on patients with diabetes being treated in multi-physician primary care practice. The study looked at the number of patients with diabetes over the course of a year who had the recommended retinal examination before the installation of a telemedicine remote imaging system in the practice versus the number of patients with diabetes who had a retinal examination in the two years following installation of the device.

"In the past, it has been shown that telemedicine is technically possible, but this study demonstrates the true impact of a telemedicine system on the number of patients with diabetes who end up having an evaluation for diabetic retinopathy," said Ingrid Zimmer-Galler, MD, assistant professor of ophthalmology at the Wilmer Eye Institute at the Johns Hopkins School of Medicine. "With this system, we've dramatically increased the rate of annual retinal evaluations."

In the first year, out of 1,257 diabetic patients in the study, only 15 percent had a retinal examination. Two years after implementation of the telemedicine system, 71 percent of the 1,395 diabetic patients in the practice had a retinal examination. Significantly, of the observed increase, 66 percent was due to an eye examination by a local ophthalmologist and only 33 percent was due to remote evaluation.

"It's very nice to see that increased rate of evaluations was not solely because these patients were undergoing remote imaging," said Dr. Zimmer- Galler. "It shows that by having this type of system in place, overall awareness of the problem increased and had a beneficial affect on all patients."

Incre
'/>"/>

SOURCE American Academy of Ophthalmology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...AND,Colo.,Nov.25/PRNewswire-FirstCall/--HeskaCorpo...ddiagnosticandspecialtyproductstotheveterinaryindu...orporationforthesupplyofbloodgasproductsandaffilia... http://www.newscom.com/cgi-bin/prnh/20000622/HESK...innovatinginthefieldofadvancedpoint-of-carediagnos...
(Date:11/25/2009)...,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,In... report,thefirstinamulti-phasesyndicatedmarketres...ch,sStelara,fromproductlaunchthroughthefirstsixmon...itativeinformationfrom75uniqueDermatologistsandqua...strialanduseofStelara,obstaclestouse,typicalpatien...
(Date:11/25/2009)...NGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences...hromboticaptamerswithactivecontrolagents,announced...gatthePiperJaffray21stAnnualHealthCareConferenceat...ntationwillbegivenat1:10pm(EST)onTuesday,December1...emphasisontheleaddevelopmentprogram,theanticoagula...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 1D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 2D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 3Genetic Discovery May Improve Hepatitis C Treatment 54618 1Genetic Discovery May Improve Hepatitis C Treatment 54618 2
...ehensive overview of clinical trials, ...AGO, Aug. 13 Aon eSolutions, the client,technolog...ding provider of,global risk and insurance solutio... Trials module as part of RiskConsole, the market-...system (RMIS)., (Logo: http://www.newscom.com/cg...
... could provide therapeutic benefit in c...ARLSBAD, Calif., Aug. 13 Isis,Pharmaceuticals, In...ed a,Phase 1 study of ISIS 353512, an antisense dr...ein (CRP). CRP levels are frequently elevated,in p...ovascular disease,Crohn,s disease, rheumatoid arth...
Other Medicine Technology:Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3
(Date:11/25/2009)...NFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualit...r Spare the Air Alert forThursday,No...logsoranyothersolidfuel,bothindoorsandoutdoors. ,...qualitytomorrow,"saidJackBroadbent,executiveoffice...spectthehealthoftheirneighborsandfellowcommunityme...
(Date:11/25/2009)...m survivors of testicular cancer who were treated ...side effects, including neurological side effects ...treated with chemotherapy, according to a new stud...the National Cancer Institute . , Marianne Brydy...niversity Hospital, in Bergen, Norway, and colleag...
(Date:11/25/2009)...uitous discovery that grew out of a collaboration ...ially offer hope to the nearly 10 million American... , Also known as hardening of the arteries, peri...latory problem in which narrowed arteries reduce b...d a red flag for vascular disease, heart attack an...
(Date:11/25/2009)...follow-up period was too short to draw definite co...Nov. 25 (HealthDay News) -- In diabetic patients w... no difference in outcomes at one year whether pat...tenting, British researchers report. , Bypass s...c patients with coronary artery disease. However, ...
(Date:11/25/2009)... Evaluation and treatment clinics t... Woodstock (Vocus) November 25, 2009 -- Centegra ...ccines and H1N1 vaccine shots at four Centegra Pri...shipment of vaccine has arrived. The clinics are a...d McHenry and will be open as follows: ,  ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...al economic shutdown as some 2 million public ser...pute . 'It's going to be a total shutdown tomorrow... a massive strike involving marches in major citie... warned Tuesday. The comment came after ye...
... unconscious in his Kingston hotel room on 18 Marc...orld Cup . An initial pathologist's report had con... the Pakistan team was fingerprinted before return...ent expert opinions had concluded that the origina...
...turn the tables by declaring that some recent impo... standards and destroyed them . That was apparentl...the safety of a variety of products exported by Ch... in the north-eastern part of the country have bee...
...inated with carcinogens, for thirty years, a speci... and Prevention, reveals . The soldiers based...that contained around 40 times the safety limits o...of various forms of cancers and other illnesses am...
...g vaccines for children which are permissible unde...s here Tuesday ahead of an inaugural health confer...cials from the Organisation of the Islamic Confere...lu outbreaks and outbreaks of other infectious dis...
...re than leave you short-tempered: it can also stre...r disease and death, according to a study released...ural effects of long-term sleep loss have been wel...a School of Medicine adds to a growing body of evi...
Other Medicine News:Health News:South Africa Facing Major Economic Shutdown as Health Workers are Sacked En Masse 2Health News:No Foul Play, Woolmer Died of Naural Causes, Say Jamaican Police 2Health News:China Admits Fake Blood Protein Used in Drips 2Health News:Child Vaccines a Key Issue for OIC Forum in Malaysia 2Health News:Insufficient Sleep Increases Risk of Cardiovascular Disease: Study 2
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: